GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Debt-to-Equity

OrthoPediatrics (OrthoPediatrics) Debt-to-Equity : 0.03 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Debt-to-Equity?

OrthoPediatrics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.2 Mil. OrthoPediatrics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $9.9 Mil. OrthoPediatrics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $377.0 Mil. OrthoPediatrics's debt to equity for the quarter that ended in Dec. 2023 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for OrthoPediatrics's Debt-to-Equity or its related term are showing as below:

KIDS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.22   Max: 2.93
Current: 0.03

During the past 10 years, the highest Debt-to-Equity Ratio of OrthoPediatrics was 2.93. The lowest was 0.00. And the median was 0.22.

KIDS's Debt-to-Equity is ranked better than
87.5% of 712 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs KIDS: 0.03

OrthoPediatrics Debt-to-Equity Historical Data

The historical data trend for OrthoPediatrics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrthoPediatrics Debt-to-Equity Chart

OrthoPediatrics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.01 0.01 - 0.03

OrthoPediatrics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.03

Competitive Comparison of OrthoPediatrics's Debt-to-Equity

For the Medical Devices subindustry, OrthoPediatrics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrthoPediatrics's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Debt-to-Equity falls into.



OrthoPediatrics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

OrthoPediatrics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

OrthoPediatrics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrthoPediatrics  (NAS:KIDS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


OrthoPediatrics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


OrthoPediatrics (OrthoPediatrics) Business Description

Traded in Other Exchanges
Address
2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Executives
Terry D Schlotterback director 2850 FRONTIER DRIVE, WARSAW IN 46582
Fred Hite director, officer: Chief Financial Officer ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Dyer George Sinclair Mitchell director 55 ORCHARD ST., CAMBRIDGE MA 02140
Gregory A Odle officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Joseph W Hauser officer: Sr VP & GM Trauma & Deformity 6428 RIDGELINE DR, HUDSON OH 44236
Jimmy Duane Mcdonald director 28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc 10 percent owner 18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc 10 percent owner 2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf director 2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C director 2850 FRONTIER DR, WARSAW IN 46582
Stephen F Burns director 2850 FRONTIER DRIVE, WARSAW IN 46582
Berry Bernie B Iii director 2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl director, officer: President and CEO ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582